Literature DB >> 1910078

A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content.

P Gaetani1, G Butti, C Chiabrando, M Danova, M G Castelli, A Riccardi, R Assietti, P Paoletti.   

Abstract

The study of proliferative characteristics and biochemical aspects seem to be of great importance in order to define brain neoplastic behavior. The purpose of this study is to verify the existence of any possible correlation between Arachidonic Acid (AA) metabolism and proliferative characteristics in 30 meningiomas and 30 neuroepithelial tumors. The most represented metabolite in neuroepithelial tumors is TxB2, while 6-Keto-PGF1 alpha is the lowest represented product. Unimodal DNA distribution was observed in 66% of neuroepithelial tumors and in 87% of meningiomas. Aneuploidy was more frequent in glioblastomas and anaplastic meningiomas as previously reported; AA overall synthesis capacity and profile were similar between unimodal and bimodal cases of neuroepithelial tumors. Total AA metabolite, as well as TxB2 and PGD2, synthesis capacity are significantly higher in cases with S-phase cell percentage greater than or equal to 3% than in cases with S-phase % less than 3%. Total production of AA metabolites via the cyclooxygenase pathway is significantly higher in meningiomas with bimodal DNA distribution than in cases with unimodal DNA content; when considering S-phase cell percentage, similarly to what observed in neuroepithelial tumors, meningiomas with S% greater than 3% shows a significantly higher overall synthesis capacity for AA. AA metabolism capacity well correlates with proliferative patterns in neuroepithelial tumors: the relationship depends preferentially on TxB2 and PGD2 synthesis capacity. In cases of meningiomas, the amount of AA metabolites seem to be related to DNA content and proliferative activity when anaplastic features are histologically demonstrated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910078     DOI: 10.1007/bf00177535

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Cell microfluorometry: a method for rapid fluorescence measurement.

Authors:  M A Van Dilla; T T Trujillo; P F Mullaney; J R Coulter
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

2.  The relationship between concentrations of prostaglandin A1, E1, E2 and E2alpha and rates of cell proliferation.

Authors:  R A Karmali; D F Horrobin; J Menezes; P Patel
Journal:  Pharmacol Res Commun       Date:  1979-01

3.  Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2alpha.

Authors:  L J De Asua; D Clingan; P S Rudland
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

4.  Cell kinetic analyses of human malignant brain tumors (gliomas).

Authors:  T Hoshino; C B Wilson
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

5.  Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.

Authors:  C Chiabrando; M Broggini; M G Castelli; E Cozzi; M N Castagnoli; M G Donelli; S Garattini; R Giavazzi; R Fanelli
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

6.  Labeling indices of human lung cancer. Correlation with histologic type and survival.

Authors:  R E Moran; M J Straus
Journal:  Anal Quant Cytol       Date:  1983-12

Review 7.  Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.

Authors:  K V Honn; R S Bockman; L J Marnett
Journal:  Prostaglandins       Date:  1981-05

8.  Prostaglandins, steroids and human mammary cancer.

Authors:  J Watson; S Y Chuah
Journal:  Eur J Cancer Clin Oncol       Date:  1985-09

9.  Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.

Authors:  T Nagashima; T Hoshino; K G Cho; M Senegor; F Waldman; K Nomura
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

10.  Prostaglandin and thromboxane synthesis by human intracranial tumors.

Authors:  M G Castelli; C Chiabrando; R Fanelli; L Martelli; G Butti; P Gaetani; P Paoletti
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

View more
  5 in total

Review 1.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

2.  LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.

Authors:  Ravindra Varma Polisetty; Poonam Gautam; Rakesh Sharma; H C Harsha; Sudha C Nair; Manoj Kumar Gupta; Megha S Uppin; Sundaram Challa; Aneel Kumar Puligopu; Praveen Ankathi; Aniruddh K Purohit; Giriraj R Chandak; Akhilesh Pandey; Ravi Sirdeshmukh
Journal:  Mol Cell Proteomics       Date:  2012-01-04       Impact factor: 5.911

3.  Inhibition of cell proliferation and glutathione S-transferase by ascorbyl esters and interferon in mouse glioma.

Authors:  A K Naidu; M Wiranowska; S H Kori; K C Roetzheim; A P Kulkarni
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

4.  A study on the biological behavior of human brain tumors. Part II: Steroid receptors and arachidonic acid metabolism.

Authors:  G Butti; P Gaetani; C Chiabrando; R Assietti; C Zibera; M G Castelli; N Gibelli; V Silvani; G Robustelli della Cuna; P Paoletti
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

Review 5.  The eicosanoid cascade: possible role in gliomas and meningiomas.

Authors:  N Nathoo; G H Barnett; M Golubic
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.